Evoke Pharma Total Current Liabilities 2012-2024 | EVOK

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Evoke Pharma total current liabilities from 2012 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.

Evoke Pharma Total Current Liabilities 2012-2024 | EVOK

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Evoke Pharma total current liabilities from 2012 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$19.4B
Dr Reddy's Laboratories (RDY)	$11.9B
BridgeBio Pharma (BBIO)	$4.4B
Bausch Health Cos (BHC)	$2.9B
Amphastar Pharmaceuticals (AMPH)	$2.2B
Supernus Pharmaceuticals (SUPN)	$2B
Taysha Gene Therapies (TSHA)	$506M
Personalis (PSNL)	$245M
Assembly Biosciences (ASMB)	$96M
Sol-Gel Technologies (SLGL)	$15M
Teligent (TLGT)	$0M